文献速递神经CTMR

对比增强CT中频率选择性非线性融合对脑转移瘤可检测性的评估

Detectability of Brain Metastases by Using Frequency-Selective Nonlinear Blending in Contrast-Enhanced Computed Tomography.
PubMed 文献 · Invest Radiol · 2019-01-01

该回顾性研究纳入91例同时行脑对比增强CT和MRI的患者(共173个脑转移灶),以MRI为参考标准,比较线性融合与频率选择性非线性融合(FS-NLB)对脑转移瘤的检测效能。FS-NLB显著提高对比噪声比,敏感度从40%升至62%,但特异度从98%降至94%,且敏感度仍低于MRI。

要点

  • FS-NLB后处理显著提高脑转移灶对比噪声比,高密度灶从9.11升至18.1,低密度灶从6.3升至17.8。
  • FS-NLB敏感度62%高于线性融合的40%,但特异度94%低于线性融合的98%。
  • FS-NLB对转移瘤患者治疗相关分组能力略逊于MRI。

核心结论

  • 对比增强CT的FS-NLB后处理较常规CT显著提高脑转移瘤检出,但敏感度仍低于MRI,且治疗相关分组能力略逊于MRI。

研究设计与样本

  • 回顾性研究,本院2014至2016年数据检索纳入91例同时行脑对比增强CT和MRI筛查脑转移瘤的患者(n=173个转移灶),平均时间间隔29±37天(恶性15±16天/良性42±47天);以脑MRI共识判读为参考标准,两位阅片者独立先评线性融合CT、洗脱期后评FS-NLB CT。

关键影像表现/征象

  • 高密度脑转移瘤最佳FS-NLB设置为中心47 HU、差值5 HU、斜率5。
  • 低密度脑转移瘤最佳FS-NLB设置为中心32 HU、差值5 HU、斜率5。

诊断标准与关键数值

  • 高密度脑转移瘤对比噪声比:对比增强CT 9.11(6.9-10.9)vs FS-NLB 18.1(11.9-22.8),P<0.0001。
  • 低密度脑转移瘤对比噪声比:对比增强CT 6.3(5.2-8)vs FS-NLB 17.8(14.5-19.7),P<0.0001。
  • 线性融合与FS-NLB的敏感度、特异度、阴性预测值、阳性预测值、准确率分别为40%、98%、99%、31%、52%与62%、94%、97%、40%、69%。
  • 按转移灶数量分5组(0无转移、1单发、2少于4个、3大于4且小于10个、4大于10个),MRI、线性融合、FS-NLB各组例数分别为0组(47、47、46)、1组(14、8、11)、2组(16、12、15)、3组(8、7、8)、4组(6、4、6)。

局限性

  • FS-NLB敏感度仍低于MRI。
  • FS-NLB对患者治疗相关分组能力略逊于MRI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study to evaluate the role of frequency-selective nonlinear blending (FS-NLB) for the detectability of brain metastases with contrast-enhanced computed tomography (CECT) using magnetic resonance imaging (MRI) as standard of reference.

MATERIALS AND METHODS: A retrospective patient data search at our institution yielded 91 patients who underwent both brain CECT and MRI for screening of brain metastases (n = 173) between 2014 and 2016 (mean time interval, 29 ± 37 [malignant: 15 ± 16/benign: 42 ± 47] days). A recently introduced FS-NLB postprocessing technique was applied to CECT images. Two readers interpreted all CT images in an independent fashion. The conventional, linear blending (LB) CT images were evaluated first. After a washout period, the same readers evaluated the FS-NLB CT images. The standard of reference was established by a consensus interpretation of the brain MRI studies. Outcome variables included determination of best performing FS-NLB settings, region of interest (ROI)-based calculation of contrast-to-noise ratios (CNRs), size, and number of brain metastases. Based on the number of metastases, we classified patients in 5 therapeutically relevant categories (0, no metastasis; 1, singular metastasis; 2, less than 4 metastases; 3, >4 and <10 metastases; 4, >10 metastases). Statistical comparison and diagnostic performance tests were applied.

RESULTS: A center of 47 Hounsfield units (HU), delta of 5 HU, and slope of 5 resulted in the best delineation of hyperdense brain metastases, whereas for hypodense brain metastases, a center of 32 HU, delta of 5 HU, and slope of 5 showed best delineation. Frequency-selective nonlinear blending significantly increased CNR in hyperdense cerebral metastases (CECT: 9.11 [6.9-10.9], FS-NLB: 18.1 [11.9-22.8]; P < 0.0001) and hypodense cerebral metastases (CECT: 6.3 [5.2-8], FS-NLB: 17.8 [14.5-19.7]; P < 0.0001). Sensitivity, specificity, negative predictive values, positive predictive values, and accuracy for LB, and FS-NLB were 40%, 98%, 99%, 31%, and 52%, and 62%, 94%, 97%, 40%, and 69%, respectively. Magnetic resonance imaging, LB, and FS-NLB classification of metastatic patients were group 0 (47, 47, 46), group 1 (14, 8, 11), group 2 (16, 12, 15), group 3 (8, 7, 8), and group 4 (6, 4, 6).

CONCLUSIONS: Frequency-selective nonlinear blending postprocessing of CECT significantly increases the detection of brain metastases over conventional CECT; however, the sensitivity remains lower than MRI. Frequency-selective nonlinear blending is slightly inferior in the categorization of patients into therapeutically relevant groups, when compared with MRI.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Bongers MN, Bier G, Schabel C, et al. Detectability of Brain Metastases by Using Frequency-Selective Nonlinear Blending in Contrast-Enhanced Computed Tomography. Invest Radiol. 2019. PMID: 30281555. doi:10.1097/RLI.0000000000000514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。